Answers are grounded in this paper and cite their sources.
, has nootropic, neuroprotective, and anti-depressant properties. Neuroprotective entities generally are impermeable across the brain membrane, and this hassle can be resolved by using drug-encapsulated polymeric nanoparticles (NPs). Epileptic seizures are linked to the increased expression of fractalkine, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptors, and mammalian target of rapamycin (mTOR) dysregulation. This study investigated the effect of BM4 encapsulated poly(lactic-co-glycolic acid) (PLGA)-polyethylene glycol (PEG)-nanoparticles (BM4NP) in comprehending seizure and its ability to protect brain tissues from kainic acid (KA)-induced excitotoxicity associated neuroinflammation, oxidative stress, and over-expression of seizure markers. The optimal size (87.31 ± 9.2 nm) and zeta potential (-18.8 ± 4.7 mV) of BM4NP resulted in efficient drug loading and release kinetics. Our data demonstrated that BM4NP reduced KA-induced brain tissue damage, by restoring normal nuclear outline and strengthening brain membrane integrity. BM4NP also suppressed the over-expression of fractalkine, AMPA receptors, and mTORC1 signaling and increased antioxidant levels, suggesting it as a therapeutic agent to contain seizures.
No takes yet. Share an insight, caveat, or question.
Sekhar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: